BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? World J Gastroenterol 2016; 22(32): 7236-7251 [PMID: 27621571 DOI: 10.3748/wjg.v22.i32.7236]
URL: https://www.wjgnet.com/1007-9327/full/v22/i32/7236.htm
Number Citing Articles
1
Ahmed Swelam, René Adam, Lelde Lauka, Luiza Basilio Rodrigues, Sherif Elgarf, Mylène Sebagh, Nicolas Golse, Antonio Sa Cunha, Daniel Cherqui, Denis Castaing, Marc‐Antoine Allard. A Model to Predict Significant Macrosteatosis in Hepatic GraftsWorld Journal of Surgery 2020; 44(4): 1270 doi: 10.1007/s00268-019-05330-2
2
Ivana Mikolasevic, Goran Hauser, Maja Mijic, Viktor Domislovic, Delfa Radic-Kristo, Zeljko Krznaric, Melanija Razov-Radas, Tajana Pavic, Marija Matasin, Tajana Filipec Kanizaj, Kevork Peltekian. Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness MeasurementsCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6657047
3
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Carla Marinho, Rui Pinto, Washington Costa, José Pinto Correia, José Cotter. Transient elastography: should XL probe be used in all overweight patients?Scandinavian Journal of Gastroenterology 2019; 54(8): 1022 doi: 10.1080/00365521.2019.1644367
4
Sihem Berdja, Lynda Boudarene, Leila Smail, Samia Neggazi, Saliha Boumaza, Abdelhamid Sahraoui, El-mehdi Haffaf, Ghouti Kacimi, Souhila Aouichat Bouguerra, Fatima Martel. Scolymus hispanicus (Golden Thistle) Ameliorates Hepatic Steatosis and Metabolic Syndrome by Reducing Lipid Accumulation, Oxidative Stress, and Inflammation in Rats under Hyperfatty DietEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5588382
5
Lea Ladegaard Grønkjær, Charlotte Wernberg, Mette Munk Lauridsen. Non-alcoholic fatty liver disease: the role of the nurseGastrointestinal Nursing 2020; 18(Sup6): S15 doi: 10.12968/gasn.2020.18.Sup6.S15
6
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, Arun J. Sanyal. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature reviewDiabetes, Obesity and Metabolism 2021; 23(5): 1069 doi: 10.1111/dom.14322
7
Andre Fialho, Andrea Fialho, Bruno Ribeiro, Miguel Malespin, Silvio De Melo, Ron Schey, Peter Ghali. Association Between Helicobacter pylori and Steatosis Severity on Transient Elastography Cureus 2023;  doi: 10.7759/cureus.34042
8
Bianca Senger Vasconcelos Barros, Fernanda Cruz Monteiro, Carlos Terra, Marilia Brito Gomes. Prevalence of non-alcoholic fatty liver disease and its associated factors in individuals with type 1 diabetes: a cross-sectional study in a tertiary care center in BrazilDiabetology & Metabolic Syndrome 2021; 13(1) doi: 10.1186/s13098-021-00649-0
9
Lili Niu, Philipp E Geyer, Nicolai J Wewer Albrechtsen, Lise L Gluud, Alberto Santos, Sophia Doll, Peter V Treit, Jens J Holst, Filip K Knop, Tina Vilsbøll, Anders Junker, Stephan Sachs, Kerstin Stemmer, Timo D Müller, Matthias H Tschöp, Susanna M Hofmann, Matthias Mann. Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver diseaseMolecular Systems Biology 2019; 15(3) doi: 10.15252/msb.20188793
10
Adele Taibbi, Salvatore Petta, Domenica Matranga, Giovanni Caruana, Roberto Cannella, Gabriele Busè, Vito Di Marco, Massimo Midiri, Tommaso Vincenzo Bartolotta. Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastographyUltrasonography 2021; 40(3): 407 doi: 10.14366/usg.20147
11
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca. The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic ReviewDiagnostics 2023; 13(21): 3316 doi: 10.3390/diagnostics13213316
12
Ying-Hsiu Lin, Yung-Liang Wan, Dar-In Tai, Jeng-Hwei Tseng, Chiao-Yin Wang, Yu-Wei Tsai, Yi-Ru Lin, Tu-Yung Chang, Po-Hsiang Tsui. Considerations of Ultrasound Scanning Approaches in Non-alcoholic Fatty Liver Disease Assessment through Acoustic Structure QuantificationUltrasound in Medicine & Biology 2019; 45(8): 1955 doi: 10.1016/j.ultrasmedbio.2019.04.018
13
Valerio Nobili, Anna Alisi, Luca Valenti, Luca Miele, Ariel E. Feldstein, Naim Alkhouri. NAFLD in children: new genes, new diagnostic modalities and new drugsNature Reviews Gastroenterology & Hepatology 2019; 16(9): 517 doi: 10.1038/s41575-019-0169-z
14
Cosmas Rinaldi Adithya Lesmana, Yoppi Kencana, Ikhwan Rinaldi, Juferdy Kurniawan, Irsan Hasan, Andri Sanityoso Sulaiman, Rino Alvani Gani. Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP)Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 15 doi: 10.2147/DMSO.S330526
15
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound ElastographyCancers 2020; 12(10): 2778 doi: 10.3390/cancers12102778
16
Junghoan Park, Jeong Min Lee, Gunwoo Lee, Sun Kyung Jeon, Ijin Joo. Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound TechniquesKorean Journal of Radiology 2022; 23(1): 13 doi: 10.3348/kjr.2021.0112
17
Emily Truong, Mazen Noureddin. The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney DiseaseClinics in Liver Disease 2022; 26(2): 213 doi: 10.1016/j.cld.2022.01.008
18
Zora Meyer, Nikolaus Haas, Richard Mühlberg, Annabell Braun, Markus Fischer, Guido Mandilaras. Transient liver elastography in the follow-up of Fontan patients: results of a nation wide survey in GermanyFrontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1194641
19
Winda P. Bastian, Irsan Hasan, C. Rinaldi A. Lesmana, Ikhwan Rinaldi, Rino A. Gani. Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 CasesCase Reports in Gastroenterology 2019; 13(1): 125 doi: 10.1159/000498946
20
Haruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, Shogo Ohkoshi. Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese PopulationJournal of Clinical and Translational Hepatology 2019; 7(2): 1 doi: 10.14218/JCTH.2018.00048
21
Lindsey C. Shipley, Page D. Axley, Ashwani K. Singal. Liver Fibrosis: A Clinical UpdateEMJ Hepatology 2019; : 105 doi: 10.33590/emjhepatol/10313576
22
Qiang Zeng, Zhenya Song, Yi Zhao, Jianjun Wu, Liuhong Wang, Huiyi Ye, Yingwei Wang, Ting Wu, Sishu Yuan, Haojie Yuan. Controlled attenuation parameter by vibration‐controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging‐based proton density fat fractionHepatology Research 2020; 50(5): 578 doi: 10.1111/hepr.13481
23
Dieter Broering, Mohamed Shawkat, Ali Albenmousa, Faisal Abaalkhail, Saleh Alabbad, Waleed Al-Hamoudi, Saad Alghamdi, Saleh Alqahthani, Ahmad Jaafari, Roberto Troisi, Khalid Bzeizi, Frank JMF Dor. Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donorsPLOS ONE 2021; 16(5): e0251487 doi: 10.1371/journal.pone.0251487
24
Fernando de Barros, Ana Beatriz Monteiro Fonseca. Bariatric surgery during the evolution of fatty liver–A randomized clinical trial comparing gastric bypass and sleeve gastrectomy based on transient elastographyClinical Obesity 2020; 10(6) doi: 10.1111/cob.12393
25
Tarik A.A. Hassan, Ayman Kamal, Mona Kaddah, Karim Mostafa, Wael Omar. Assessment of hepatic steatosis before and after laparoscopic sleeve gastrectomyThe Egyptian Journal of Surgery 2023; 42(2): 543 doi: 10.4103/ejs.ejs_90_23
26
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
27
Jelte J. Schaapman, Maarten E. Tushuizen, Minneke J. Coenraad, Hildo J. Lamb. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver DiseaseJournal of Magnetic Resonance Imaging 2021; 53(6): 1623 doi: 10.1002/jmri.27292
28
Reyhaneh Darvish Damavandi, Farzad Shidfar, Mohammad Najafi, Leila Janani, Mohsen Masoodi, Maryam Akbari‐Fakhrabadi, Afsaneh Dehnad. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double‐blind clinical trialPhytotherapy Research 2021; 35(6): 3145 doi: 10.1002/ptr.6972
29
Bisher Sawaf, Adel Hajj Ali, Rola F. Jaafar, Mariam Kanso, Deborah Mukherji, Mohamad J. Khalife, Walid Faraj. Spectrum of liver diseases in patients referred for Fibroscan: A single center experience in the Middle EastAnnals of Medicine and Surgery 2020; 57: 166 doi: 10.1016/j.amsu.2020.07.040
30
I G Bakulin, Yu G Sandler, E V Vinnitskayа, V A Keiyan, S V Rodionova, D L Rotin. Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingencyTerapevticheskii arkhiv 2017; 89(2): 59 doi: 10.17116/terarkh201789259-65
31
Maëna Le Corvec, Marwin A. Farrugia, Eric Nguyen-Khac, Jean-Marc Régimbeau, Abdennaceur Dharhri, Denis Chatelain, Litavan Khamphommala, Anne-Lise Gautier, Nathalie Le Berre, Sébastien Frey, Jean-Pierre Bronowicki, Laurent Brunaud, Chloé Maréchal, Marie-Cécile Blanchet, Vincent Frering, Jean Delwaide, Laurent Kohnen, Alexandre Haumann, Philippe Delvenne, Marine Sarfati-Lebreton, Hugues Tariel, Jérôme Bernard, Alexis Toullec, Jérôme Boursier, Pierre Bedossa, Philippe Gual, Rodolphe Anty, Antonio Iannelli. Blood-based MASH diagnostic in candidates for bariatric surgery using mid-infrared spectroscopy: a European multicenter prospective studyScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-72704-5
32
Antoine Moret, Jérome Boursier, Pauline Houssel Debry, Jérémie Riou, Anne Crouan, Marine Dubois, Sophie Michalak Provost, Christophe Aubé, Anita Paisant. Evaluation of the Hepatorenal B-Mode Ratio and the “Controlled Attenuation Parameter” for the Detection and Grading of SteatosisUltraschall in der Medizin - European Journal of Ultrasound 2022; 43(05): 479 doi: 10.1055/a-1233-2290
33
Adelaida Solomon, Mihai Octavian Negrea, Călin Remus Cipăian, Adrian Boicean, Romeo Mihaila, Cristina Rezi, Bianca Andreea Cristinescu, Cristian Stefan Berghea-Neamtu, Mirela Livia Popa, Minodora Teodoru, Oana Stoia, Bogdan Neamtu. Interactions between Metabolic Syndrome, MASLD, and Arterial Stiffening: A Single-Center Cross-Sectional StudyHealthcare 2023; 11(19): 2696 doi: 10.3390/healthcare11192696
34
Arthur Pearson, Paul‐Armand Dujardin, Louis d'Alteroche, Frédéric Patat, Béatrice Scotto, Fanny Dujardin, Cécile Bastard, Véronique Miette, Laurent Sandrin, Jean‐Pierre Remenieras. Vibration‐controlled transient elastography for noninvasive evaluation of liver steatosisMedical Physics 2022; 49(3): 1507 doi: 10.1002/mp.15484
35
Elena N. Shirokova, Chavdar S. Pavlov, Anna D. Karaseva, Aliya M. Alieva, Alla V. Sedova, Vladimir T. Ivashkin. Elastography in the Diagnosis of Non-Alcoholic Fatty Liver DiseaseAnnals of the Russian academy of medical sciences 2019; 74(1): 5 doi: 10.15690/vramn1071
36
Madalina-Gabriela Taru, Lidia Neamti, Vlad Taru, Lucia Maria Procopciuc, Bogdan Procopet, Monica Lupsor-Platon. How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography—A Review of the Literature and Proposed Multistep ApproachDiagnostics 2023; 13(4): 788 doi: 10.3390/diagnostics13040788
37
I. Mikolasevic, V. Lukenda Zanko, I. Jakopcic, V. Domislovic, A. Mijic, T. Stevanovic, B. Delija, T. Bokun, P. Dinjar Kujundzic, A. Ostojic, T. Filipec Kanizaj, I. Grgurevic, Z. Krznaric, D. Stimac, G. Targher. Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurementsJournal of Diabetes and its Complications 2020; 34(3): 107512 doi: 10.1016/j.jdiacomp.2019.107512
38
Afina Bestavashvili, Oleg Glazachev, Alexander Bestavashvili, Alexander Suvorov, Yong Zhang, Xinliang Zhang, Andrey Rozhkov, Natalia Kuznetsova, Chavdar Pavlov, Dmitriy Glushenkov, Philippe Kopylov. Intermittent Hypoxic-Hyperoxic Exposures Effects in Patients with Metabolic Syndrome: Correction of Cardiovascular and Metabolic ProfileBiomedicines 2022; 10(3): 566 doi: 10.3390/biomedicines10030566
39
Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong. Application of transient elastography in nonalcoholic fatty liver diseaseClinical and Molecular Hepatology 2020; 26(2): 128 doi: 10.3350/cmh.2019.0001n
40
Eron G. Manusov, Vincent P. Diego, Marcio Almeida, David Ortiz, Joanne E. Curran, Jacob Galan, Ana C. Leandro, Sandra Laston, John Blangero, Sarah Williams-Blangero. Genotype-by-Environment Interactions in Nonalcoholic Fatty Liver Disease and Chronic Illness among Mexican Americans: The Role of Acculturation StressGenes 2024; 15(8): 1006 doi: 10.3390/genes15081006
41
Xinyu Yang, Xinxia Chang, Shengdi Wu, Xiaoyang Sun, Xiaopeng Zhu, Liu Wang, Yushan Xu, Xiuzhong Yao, Shengxiang Rao, Xiqi Hu, Mingfeng Xia, Hua Bian, Hongmei Yan, Xin Gao. Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver diseaseLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01453-5
42
Ying-Hsiu Lin, Yin-Yin Liao, Chih-Kuang Yeh, Kuen-Cheh Yang, Po-Hsiang Tsui. Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic SyndromeEntropy 2018; 20(12): 893 doi: 10.3390/e20120893
43
Sarunporn Kamolvisit, Supphamat Chirnaksorn, Hataikarn Nimitphong, Somnuek Sungkanuparph. Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and PrediabetesCureus 2021;  doi: 10.7759/cureus.19046
44
Duo-Duo Lv, You-Juan Wang, Meng-Lan Wang, En-Qiang Chen, Ya-Chao Tao, Dong-Mei Zhang, Hong Tang. Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis BScientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80709-z
45
Dan Lv, Zepu Wang, Cuiqiao Meng, Yan Li, Shuai Ji. A study of the relationship between serum asprosin levels and MAFLD in a population undergoing physical examinationScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62124-w
46
Marek Frankowski, Jerzy Świerkot, Marek Gomułkiewicz, Lucyna Korman, Marta Skoczyńska, Aleksandra Starba. Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritisRheumatology International 2022; 42(4): 631 doi: 10.1007/s00296-021-05059-z
47
Pauline Tortajada, Rodrigue Doamba, Luis Cano, Mohammed Ghallab, Marc Antoine Allard, Oriana Ciacio, Gabriella Pittau, Chady Salloum, Daniel Cherqui, René Adam, Antonio Sa Cunha, Daniel Azoulay, Alina Pascale, Eric Vibert, Nicolas Golse. Resectable and transplantable hepatocellular carcinoma: Integration of liver stiffness assessment in the decision-making algorithmSurgery 2022; 172(6): 1704 doi: 10.1016/j.surg.2022.08.012
48
Yanal Alnimer, Touleen Alnimer, Kevork M. Peltekian. Prediction of Liver Steatosis and Fibrosis Based on Clinical Variables Using a Large National Survey DatabaseCanadian Journal of Gastroenterology and Hepatology 2023; 2023: 1 doi: 10.1155/2023/1791500
49
Mohammad Alizadeh, Mohammadreza Mohammad Hosseiniazar, Farkhondeh Alami, Somayyeh Bararnia Adabi. The effects of meal patterns on liver steatosis, fibrosis, and biochemical factors in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trialJournal of Diabetes & Metabolic Disorders 2024; 23(1): 987 doi: 10.1007/s40200-023-01375-2
50
Rishi Philip Mathew, Sudhakar Kundapur Venkatesh. Imaging of Hepatic FibrosisCurrent Gastroenterology Reports 2018; 20(10) doi: 10.1007/s11894-018-0652-7
51
Ivana Mikolasevic, Andela Lukic, Toni Juric, Mia Klapan, Petra Madzar, Nikola Krolo, Doris Kolovrat, Ivanka Jurica, Iva Kedmenec, Domagoj Kihas, Doris Ilovaca, Ivan Erstic, Vanda Haralovic, Danijel Cavlina, Ema Dejhalla, Danijela Erdeljac, Benjamin Vukalovic, Nadija Skenderevic, Sandra Milic. Non-alcoholic fatty liver disease and transient elastographyExploration of Medicine 2020; 1(4): 205 doi: 10.37349/emed.2020.00014
52
Wolhwa Song, Sung Hwan Yoo, Jinsun Jang, Su Jung Baik, Byoung Kwon Lee, Hyun Woong Lee, Jong Suk Park. Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and FibrosisGut and Liver 2023; 17(1): 130 doi: 10.5009/gnl220041
53
Tilman Kühn, Tobias Nonnenmacher, Disorn Sookthai, Ruth Schübel, Daniel Antonio Quintana Pacheco, Oyunbileg von Stackelberg, Mirja E. Graf, Theron Johnson, Christopher L. Schlett, Romy Kirsten, Cornelia M. Ulrich, Rudolf Kaaks, Hans-Ulrich Kauczor, Johanna Nattenmüller. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adultsBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0840-9
54
Elham Ehrampoush, Alireza Ghaemi, Saeed Osati, Maryam Maleki, Hadi Raeisi Shahraki, Behnam Honarvar, Maryam Bahmanyar, Reza Homayounfar. The Association Between Serum Vitamin D Level and Nonalcoholic Fatty Liver DiseaseHepatitis Monthly 2019; 19(9) doi: 10.5812/hepatmon.92992
55
Gabriela Handzlik, Michał Holecki, Joanna Kozaczka, Michał Kukla, Katarzyna Wyskida, Leszek Kędzierski, Krzysztof Pawlicki, Jan Duława. Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver diseasePharmacological Reports 2019; 71(2): 183 doi: 10.1016/j.pharep.2018.10.013
56
Ivana Mikolasevic, Sandra Milic, Tajana Filipec‐Kanizaj. Fatty liver allografts are associated with primary graft non‐function and high mortality after transplantationLiver International 2017; 37(8): 1113 doi: 10.1111/liv.13453
57
Antonella Mosca, Nadia Panera, Annalisa Crudele, Anna Alisi. Noninvasive diagnostic tools for pediatric NAFLD: where are we now?Expert Review of Gastroenterology & Hepatology 2020; 14(11): 1035 doi: 10.1080/17474124.2020.1801413
58
Nora A. Alfadda, Ghadeer S. Aljuraiban, Hadeel M. Awwad, Mohammad S. Khaleel, Abdulrahman M. Almaghamsi, Suphia M. Sherbeeni, Adel N. Alqutub, Abdullah S. Aldosary, Assim A. Alfadda. Higher carbohydrate intake in relation to non-alcoholic fatty liver disease in patients with type 2 diabetesFrontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.996004
59
Ivana Mikolasevic, Goran Poropat, Tajana Filipec Kanizaj, Nadija Skenderevic, Marko Zelic, Marija Matasin, Luka Vranic, Andrea Kresovic, Goran Hauser, Geoffrey Williams. Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness MeasurementsCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6670065
60
Mohammad Ariya, Farbod Koohpayeh, Alireza Ghaemi, Saeed Osati, Sayed Hossain Davoodi, Jalaledin Mirzay Razzaz, Gholamali Javedan, Elham Ehrampoush, Reza Homayounfar, Gianfranco D. Alpini. Assessment of the association between body composition and risk of non-alcoholic fatty liverPLOS ONE 2021; 16(4): e0249223 doi: 10.1371/journal.pone.0249223
61
Anne Linde Mak, Jenny Lee, Anne-Marieke van Dijk, Yasaman Vali, Guruprasad P. Aithal, Jörn M. Schattenberg, Quentin M. Anstee, M. Julia Brosnan, Mohammad Hadi Zafarmand, Dewkoemar Ramsoekh, Stephen A. Harrison, Max Nieuwdorp, Patrick M. Bossuyt, Adriaan G. Holleboom. Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseBiomedicines 2021; 9(12): 1920 doi: 10.3390/biomedicines9121920
62
Chavdar Savov Pavlov, Taisiya Alekseevna Turankova, Dar'ya Leonidovna Varganova. LIPOSOMAL TECHNOLOGIES FOR SILYBIN DELIVERY TO THE LIVER IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASEUlyanovsk Medico-biological Journal 2023; (1): 50 doi: 10.34014/2227-1848-2023-1-50-62
63
Terence N Moyana. Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening testWorld Journal of Gastroenterology 2024; 30(42): 4576-4582 doi: 10.3748/wjg.v30.i42.4576
64
Eugenia Tsai, Tai-Ping Lee. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient ElastographyClinics in Liver Disease 2018; 22(1): 73 doi: 10.1016/j.cld.2017.08.004
65
Mazen Noureddin, Micaela M Wong, Tsuyoshi Todo, Shelly C Lu, Arun J Sanyal, Edward A Mena. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antiviralsWorld Journal of Gastroenterology 2018; 24(11): 1269-1277 doi: 10.3748/wjg.v24.i11.1269
66
Paul A. Gomez, Kelly M. Zucker, Jean Chang, Michael W. Rowley, Anil B. Seetharam. Severe pretreatment hepatic steatosis influences response to direct acting antiviral therapy for chronic hepatitis C in a real world settingClinics and Research in Hepatology and Gastroenterology 2020; 44(2): e35 doi: 10.1016/j.clinre.2019.05.004
67
Aki Juhani Käräjämäki, Janne Hukkanen, Olavi Ukkola. The association of non-alcoholic fatty liver disease and atrial fibrillation: a reviewAnnals of Medicine 2018; 50(5): 371 doi: 10.1080/07853890.2018.1492147
68
Zobair M. Younossi, Mazen Noureddin, David Bernstein, Paul Kwo, Mark Russo, Mitchell L. Shiffman, Ziad Younes, Manal Abdelmalek. Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel RecommendationsAmerican Journal of Gastroenterology 2021; 116(2): 254 doi: 10.14309/ajg.0000000000001054
69
Dong Hyeon Lee, Se Un Sung, Yun Kyu Lee, Ik Hyeon Lim, Heejoon Jang, Sae Kyoung Joo, Jeong Hwan Park, Mee Soo Chang, Young Ho So, Won Kim. A sequential approach using the age‐adjusted fibrosis‐4 index and vibration‐controlled transient elastography to detect advanced fibrosis in Korean patients with non‐alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics 2022; 55(8): 994 doi: 10.1111/apt.16766
70
Benjamin M. MacCurtain, Ned P. Quirke, Stephen D. Thorpe, Tom K. Gallagher. Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and PrognosisJournal of Clinical Medicine 2021; 10(12): 2711 doi: 10.3390/jcm10122711
71
Kenji Tsunoda, Naruki Kitano, Yuko Kai, Takashi Jindo, Ken Uchida, Takashi Arao. Dose–response relationships of accelerometer‐measured sedentary behaviour and physical activity with non‐alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics 2021; 54(10): 1330 doi: 10.1111/apt.16631
72
Hong-Bae Kim, Yong-Jae Lee. Association of resting heart rate with nonalcoholic fatty liver disease in postmenopausal womenMedicine 2020; 99(14): e19529 doi: 10.1097/MD.0000000000019529
73
Ralf Weiskirchen, Frank Tacke. The Role of Radiologic Modalities in Diagnosing Nonalcoholic Steatohepatitis (NASH) and FibrosisCurrent Hepatology Reports 2018; 17(4): 324 doi: 10.1007/s11901-018-0421-y
74
Abdallah A. Elsawy, Hossam Hodeib, Ahmed F. Selim, Mohamed E. Sarhan, Ahmed A. Elhadidy, Heba M. Sameir, Amal Selim, Mohamed A. Tawfik. The possible association between blood level of free cholesterol and the severity of steatosis in patients with nonalcoholic fatty liver diseaseTanta Medical Journal 2023; 51(1): 34 doi: 10.4103/tmj.tmj_23_22
75
Jianghua Zhou, Feng Zhou, Wenxin Wang, Xiao‐Jing Zhang, Yan‐Xiao Ji, Peng Zhang, Zhi‐Gang She, Lihua Zhu, Jingjing Cai, Hongliang Li. Epidemiological Features of NAFLD From 1999 to 2018 in ChinaHepatology 2020; 71(5): 1851 doi: 10.1002/hep.31150
76
Weon Jang, Ji Soo Song. Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A ReviewDiagnostics 2023; 13(11): 1852 doi: 10.3390/diagnostics13111852
77
Eron Grant Manusov, Vincent P. Diego, Khalid Sheikh, Sandra Laston, John Blangero, Sarah Williams-Blangero. Non-alcoholic Fatty Liver Disease and Depression: Evidence for Genotype × Environment Interaction in Mexican AmericansFrontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.936052
78
Madalina-Gabriela Taru, Monica Lupsor-Platon. Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound ElastographyCancers 2023; 15(16): 4097 doi: 10.3390/cancers15164097
79
Therese Adrian, Ida M H Sørensen, Filip K Knop, Susanne Bro, Ellen L F Ballegaard, Børge G Nordestgaard, Andreas Fuchs, Klaus F Kofoed, Jørgen T Kühl, Per E Sigvardsen, Mads Hornum, Bo Feldt-Rasmussen. Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a cross-sectional studyNephrology Dialysis Transplantation 2022; 37(10): 1927 doi: 10.1093/ndt/gfab266
80
Ozge Yetginoglu, Dilek Barutcu Atas, Yusuf Yilmaz, Arzu Velioglu, Hakki Arikan, Fatma Alibaz-Oner, Haner Direskeneli, Serhan Tuglular, Ebru Asicioglu. Fibroscan detection of fatty liver and liver fibrosis in patients with systemic lupus erythematosusLupus 2022; 31(6): 723 doi: 10.1177/09612033221094708
81
Chiara Pisetta, Claudia Chillè, Giovanni Pelizzari, Marie Graciella Pigozzi, Massimo Salvetti, Anna Paini, Maria Lorenza Muiesan, Carolina De Ciuceis, Chiara Ricci, Damiano Rizzoni. Evaluation of Cardiovascular Risk in Patient with Primary Non-alcoholic Fatty Liver DiseaseHigh Blood Pressure & Cardiovascular Prevention 2020; 27(4): 321 doi: 10.1007/s40292-020-00389-8
82
Monica Lupsor-Platon. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment2018;  doi: 10.5772/intechopen.71161
83
Tavitiya Sudjaritruk, Torsak Bunupuradah, Linda Aurpibul, Pope Kosalaraksa, Nia Kurniati, Jiratchaya Sophonphan, Panruethai Trinavarat, Pannee Visrutaratna, Jiraporn Srinakarin, Nataruks Chaijitraruch, Thanyawee Puthanakit, Wing-Kin Syn. Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapyPLOS ONE 2019; 14(12): e0226375 doi: 10.1371/journal.pone.0226375
84
Yaw A Wiafe, Ijeoma C Anyitey-Kokor, Richmond A Nmai, Mary Afihene, Lewis R Roberts. Diagnostic Performance of Greyscale Ultrasound in Detecting Fatty Liver Disease in a Type 2 Diabetes Population Using FibroScan as the Reference StandardCureus 2023;  doi: 10.7759/cureus.40756
85
Rasha M. Ghaleb, Doaa M. Mohamed, Zaki M. Zaki, Nadia F. El Ameen, Ahmed Hamed. Assessment of liver fibrosis by transient elastography and procollagen III amino terminal propeptide in rheumatoid arthritis patients treated with methotrexateEgyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01323-x
86
You-Wen Tan, Xing-Bei Zhou, Yun Ye, Cong He, Guo-Hong Ge. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferaseWorld Journal of Gastroenterology 2017; 23(31): 5746-5754 doi: 10.3748/wjg.v23.i31.5746
87
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical ApplicationsDiagnostics 2021; 11(5): 842 doi: 10.3390/diagnostics11050842
88
Qichen Long, Fengming Luo, Binghui Li, Ziyang Li, Zhe Guo, Zhiyang Chen, Weimin Wu, Min Hu. Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver diseaseHepatology Communications 2024; 8(3) doi: 10.1097/HC9.0000000000000310
89
Katharina Staufer, Mirko Dengler, Heidemarie Huber, Rodrig Marculescu, Rudolf Stauber, Carolin Lackner, Hans-Peter Dienes, Danijel Kivaranovic, Christian Schachner, Markus Zeitlinger, Beatrix Wulkersdorfer, Peter Rauch, Gerhard Prager, Michael Trauner, Wolfgang Mikulits. The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosisCell Death & Disease 2017; 8(10): e3135 doi: 10.1038/cddis.2017.554
90
Zeinab Anwar ElKabbany, Eman Abdel Rahman Ismail, Eman Tawfik Hamed, Nancy Samir Elbarbary. The impact of vildagliptin as an add‐on therapy on matrix metalloproteinase‐14 levels, liver stiffness and subclinical atherosclerosis in adolescents with type 1 diabetes and non‐alcoholic steatohepatitis: A randomized controlled trialDiabetes, Obesity and Metabolism 2024; 26(12): 5857 doi: 10.1111/dom.15958
91
Sumitro Kosasih, Wong Zhi Qin, Rafiz Abdul Rani, Nazefah Abd Hamid, Ngiu Chai Soon, Shamsul Azhar Shah, Yazmin Yaakob, Raja Affendi Raja Ali. Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver DiseaseInternational Journal of Hepatology 2018; 2018: 1 doi: 10.1155/2018/9252536
92
Chetan Mandelia, Mohammad Nasser Kabbany, Sarah Worley, Praveen Kumar Conjeevaram Selvakumar. Performance Characteristics, Intra‐ and Inter‐operator Agreement of Transient Elastography in Pediatric Nonalcoholic Fatty Liver DiseaseJournal of Pediatric Gastroenterology and Nutrition 2021; 72(3): 430 doi: 10.1097/MPG.0000000000002991
93
Tinsay A. Woreta, Mark L. Van Natta, Mariana Lazo, Arunkumar Krishnan, Brent A. Neuschwander-Tetri, Rohit Loomba, Anna Mae Diehl, Manal F. Abdelmalek, Naga Chalasani, Samer Gawrieh, Srinivasan Dasarathy, Raj Vuppalanchi, Mohammad S. Siddiqui, Kris V. Kowdley, Arthur McCullough, Norah A. Terrault, Cynthia Behling, David E. Kleiner, Mark Fishbein, Paula Hertel, Laura A. Wilson, Emily P. Mitchell, Laura A. Miriel, Jeanne M. Clark, James Tonascia, Arun J. Sanyal, Pavel Strnad. Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithmsPLOS ONE 2022; 17(4): e0266859 doi: 10.1371/journal.pone.0266859
94
Hanying Liu, Xiao Li, Xiaodong Han, Yan Zhang, Yanting Gu, Lianjie Sun, Junfeng Han, Yinfang Tu, Yuqian Bao, Wenkun Bai, Haoyong Yu. Simple surrogate equations to predict controlled attenuation parameter values for screening non-alcoholic fatty liver disease in a Chinese populationFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.894895
95
Zeinab Anwar Elkabany, Rasha Tarif Hamza, Eman Abdel Rahman Ismail, Aisha Elsharkawy, Ayman Yosry, Sherief Musa, Marwa Ahmad Khalaf, Roba Maher Elgawesh, Gamal Esmat. Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameterEuropean Journal of Gastroenterology & Hepatology 2020; 32(8): 1008 doi: 10.1097/MEG.0000000000001608
96
Francesco Andreozzi, Elettra Mancuso, Elisa Mazza, Gaia Chiara Mannino, Teresa Vanessa Fiorentino, Franco Arturi, Elena Succurro, Maria Perticone, Angela Sciacqua, Tiziana Montalcini, Arturo Pujia, Giorgio Sesti. One‐hour post‐load glucose levels are associated with hepatic steatosis assessed by transient elastographyDiabetes, Obesity and Metabolism 2024; 26(2): 682 doi: 10.1111/dom.15358
97
Nicha Teeratorn, Panida Piyachaturawat, Kessarin Thanapirom, Roongruedee Chaiteerakij, Kanokwan Sonsiri, Piyawat Komolmit, Pisit Tangkijvanich, Rungsun Rerknimitr, Leon Adams, Sombat Treeprasertsuk. Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastographyJGH Open 2020; 4(2): 245 doi: 10.1002/jgh3.12252
98
Kanako Kato, Kunihiro Suzuki, Chie Aoki, Masaaki Sagara, Takafumi Niitani, Sho Wakamatsu, Kazunori Yanagi, Yoshimasa Aso. The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trialExpert Opinion on Pharmacotherapy 2017; 18(8): 743 doi: 10.1080/14656566.2017.1317748
99
Yuan Li, Shousheng Liu, Yuqiang Gao, Huan Ma, Shuhui Zhan, Yan Yang, Yongning Xin, Shiying Xuan. Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han populationBMC Biochemistry 2019; 20(1) doi: 10.1186/s12858-019-0106-3
100
Alejandro Campos-Murguía, Astrid Ruiz-Margáin, José A González-Regueiro, Ricardo U Macías-Rodríguez. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2020; 26(39): 5919-5943 doi: 10.3748/wjg.v26.i39.5919
101
Michael H. Le, Linda Henry, Ramsey Cheung, Mindie H. Nguyen. Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional AnalysisDigestive Diseases 2023; 41(5): 767 doi: 10.1159/000526503
102
Yue-Yan Hu, Ning-Ling Dong, Qiu Qu, Xu-Fan Zhao, Hong-Ju Yang. The correlation between controlled attenuation parameter and metabolic syndrome and its components in middle-aged and elderly nonalcoholic fatty liver disease patientsMedicine 2018; 97(43): e12931 doi: 10.1097/MD.0000000000012931
103
Min-Kyeong Kim, Heon-Ju Kwon, Kangsu Shin, Hyosoon Park, Hee-Yeon Woo, Chang-Hun Park, Min-Jung Kwon. Liver Fibrosis Biomarker Validation Using Machine Learning AlgorithmsLaboratory Medicine Online 2023; 13(3): 189 doi: 10.47429/lmo.2023.13.3.189
104
Celso Nilo Didoné Filho, Cleiton Jonei Reginatto, Cláudia Alexandra Pontes Ivantes, Rodrigo Strobel, Ana Paula Percicote, Marcio Petenusso, Cicero Jordan R. Sobreira da Silva, Cicero Jonas R. Benjamim, Rosana Bento Radominski. Comparison between non-invasive methods and liver histology to stratify liver fibrosis in obese patients submitted to bariatric surgeryObesity Research & Clinical Practice 2021; 15(2): 152 doi: 10.1016/j.orcp.2021.02.004
105
Nobuharu Tamaki, Yohei Koizumi, Masashi Hirooka, Norihisa Yada, Hitomi Takada, Osamu Nakashima, Masatoshi Kudo, Yoichi Hiasa, Namiki Izumi. Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement methodHepatology Research 2018; 48(10): 821 doi: 10.1111/hepr.13179
106
Laura Martínez‐Arenas, Carmen Vinaixa, Isabel Conde, Sara Lorente, Fernando Díaz‐Fontenla, Patrice Marques, Judith Pérez‐Rojas, Eva Montalvá, Ângela Carvalho‐Gomes, Marina Berenguer. FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASHLiver International 2024;  doi: 10.1111/liv.16085
107
Bei Gao, Atoosa Emami, Rongrong Zhou, Sonja Lang, Yi Duan, Yanhan Wang, Lu Jiang, Rohit Loomba, David A. Brenner, Peter Stärkel, Bernd Schnabl. Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use DisorderFrontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00370
108
Farrah Naz Hussain, Emma Rosenbluth, Kristina Martimucci Feldman, Tirtza Spiegel Strauss, Emily Schneider, Emily Schmidt-Beauchat, Clara Rodriguez-Rivas, Lois Brustman, Tatyana Kushner. Transient elastography and controlled attenuation parameter to evaluate hepatic steatosis and liver stiffness in postpartum patientsThe Journal of Maternal-Fetal & Neonatal Medicine 2023; 36(1) doi: 10.1080/14767058.2023.2190838
109
Joris T. Hepkema, Floris B. Poelmann, Annette S.H. Gouw, Robbert J. de Haas, Evelien W. Duiker, Hans Blokzijl, Joost M. Klaase. Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular CarcinomaCase Reports in Gastroenterology 2020; 14(3): 577 doi: 10.1159/000510215
110
Lucija Ruzman, Ivana Mikolasevic, Kristina Baraba Dekanic, Sandra Milic, Goran Palcevski. Advances in diagnosis of chronic liver diseases in pediatric patientsWorld Journal of Pediatrics 2018; 14(6): 541 doi: 10.1007/s12519-018-0197-8
111
Julia Y. Payne, Naim Alkhouri, Phuc Le, Michael B. Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy. Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018Hepatology Communications 2023; 7(1): e0019 doi: 10.1097/HC9.0000000000000019
112
Andrea de Diego-Sola, Agustín Castiella Eguzkiza, Luis María López Domínguez, Iratxe Urreta Barallobre, María José Sánchez Iturri, Joaquín María Belzunegui Otaño, Eva María Zapata Morcillo, Andrea de Diego-Sola, Agustin Castiella Eguzkiza, Luis María López Domínguez, Iratxe Urreta Barallobre, María José Sánchez Iturri, Cesar Antonio Egües Dubuc, Jorge Jesús Cancio Fanlo, Olga Maíz Alonso, Jesús Alejandro Valero Jaimes, María Vaamonde Lorenzo, Leire Samaniego Leoz, Joaquín Belzunegui Otaño, Eva María Zapata Morcillo. Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practiceReumatología Clínica (English Edition) 2023; 19(8): 412 doi: 10.1016/j.reumae.2022.12.002
113
Nutthachoke Mahachai, Chaiwat Washirasaksiri, Pinyapat Ariyakunaphan, Chayanis Kositamongkol, Tullaya Sitasuwan, Rungsima Tinmanee, Chonticha Auesomwang, Naruemit Sayabovorn, Thanet Chaisathaphol, Pochamana Phisalprapa, Phunchai Charatcharoenwitthaya, Weerachai Srivanichakorn. Clinical Predictive Score for Identifying Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals with Prediabetes Using Transient ElastographyJournal of Clinical Medicine 2023; 12(24): 7617 doi: 10.3390/jcm12247617
114
Marilena DURAZZO, Letizia MARZARI, Silvia BONETTO, Arianna FERRO, Maria C. GHIGO, Paola BELCI, Alessandro COLLO, Sharmila FAGOONEE. Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: diagnostic accuracy of different scoresMinerva Gastroenterologica e Dietologica 2021; 66(4) doi: 10.23736/S1121-421X.20.02753-1
115
Lin Yang, Yafei Zhu, Lu Zhou, Huimei Yin, Yan Lin, Guangsheng Wu. Transient Elastography in the Diagnosis of Pediatric Non-alcoholic Fatty Liver Disease and Its SubtypesFrontiers in Pediatrics 2022; 10 doi: 10.3389/fped.2022.808997
116
Hongye Peng, Liang Pan, Simiao Ran, Miyuan Wang, Shuxia Huang, Mo Zhao, Zhengmin Cao, Ziang Yao, Lei Xu, Qing Yang, Wenliang Lv. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adultsFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1083032
117
Andy McKay, Carlos Pantoja, Richard Hall, Sarah Matthews, Phil Spalding, Rajarshi Banerjee. Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathwayJournal of Patient-Reported Outcomes 2021; 5(1) doi: 10.1186/s41687-021-00363-5
118
Omesh Goyal, Sahil Nohria, Prerna Goyal, Jaskirat Kaur, Sarit Sharma, Ajit Sood, Rajoo Singh Chhina. Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78342-x
119
Sebastian Zenovia, Cristina Muzica, Mihaela Dimache. Essentials of Non-Alcoholic Fatty Liver Disease2023; : 107 doi: 10.1007/978-3-031-33548-8_10
120
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Maria J. Moreira, Carla Marinho, José Cotter. Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the differenceEuropean Journal of Gastroenterology & Hepatology 2019; 31(8): 998 doi: 10.1097/MEG.0000000000001319
121
Kristin E. Morrill, Victoria L. Bland, Yann C. Klimentidis, Melanie D. Hingle, Cynthia A. Thomson, David O. Garcia. Assessing Interactions between PNPLA3 and Dietary Intake on Liver Steatosis in Mexican-Origin AdultsInternational Journal of Environmental Research and Public Health 2021; 18(13): 7055 doi: 10.3390/ijerph18137055
122
Peter Lemmer, Lydia Christina Rohr, Marie Henning, Kerem Bulut, Paul Manka, Ali Canbay, Jan-Peter Sowa. Liver Stiffness Determined by Transient Elastography Is a Simple and Highly Accurate Predictor for Presence of Liver Cirrhosis in Clinical RoutineDigestive Diseases 2024; 42(3): 265 doi: 10.1159/000538426
123
Yuanhui Guo, Baixuan Shen, Yanli Xue, Ying Li. Development and validation of a non-invasive model for predicting significant fibrosis based on patients with nonalcoholic fatty liver disease in the United StatesFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1207365
124
Ivana Mikolasevic, Viktor Domislovic, Mia Klapan, Toni Juric, Andjela Lukic, Irena Krznaric-Zrnic, Dora Fuckar-Cupic, Davor Stimac, Tajana Filipec Kanizaj, Zeljko Krznaric, Delfa Radic-Kristo, Sandra Milic, Marko Martinovic, Aron Grubesic, Ivica Grgurevic. Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver DiseaseUltrasound in Medicine & Biology 2021; 47(3): 428 doi: 10.1016/j.ultrasmedbio.2020.11.015
125
Stergios Kechagias, Mattias Ekstedt, Christian Simonsson, Patrik Nasr. Non-invasive diagnosis and staging of non-alcoholic fatty liver diseaseHormones 2022; 21(3): 349 doi: 10.1007/s42000-022-00377-8
126
Chetan Mandelia, Mohammad Nasser Kabbany, Praveen Kumar Conjeevaram Selvakumar, Naim Alkhouri. The Search for Noninvasive Methods to Identify Liver Fibrosis in Children With Nonalcoholic Fatty Liver DiseaseBiomarkers in Medicine 2018; 12(3): 265 doi: 10.2217/bmm-2017-0038
127
Ya-Ju Chan, Shy-Shin Chang, Jenny L. Wu, Sen-Te Wang, Cheng-Sheng Yu. Association between liver stiffness measurement by transient elastography and chronic kidney diseaseMedicine 2022; 101(4): e28658 doi: 10.1097/MD.0000000000028658
128
Sapwarobol Suwimol, Tangkijvanich Pisit, Avihingsanon Anchalee, Kongruttanachok Narisorn, Jantarapakde Jureeporn, Jiamjarasrangsi Wiroj, Michael W. Greene. Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, ThailandPLOS ONE 2022; 17(2): e0263826 doi: 10.1371/journal.pone.0263826
129
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Obesity Facts 2024; 17(4): 374 doi: 10.1159/000539371
130
Shoukat Ali Samejo, Zaigham Abbas, Muhammad Asim. Effects of anthropometric and metabolic parameters on transaminase levels and liver stiffness in patients with non-alcohol fatty liver diseaseTropical Doctor 2021; 51(2): 185 doi: 10.1177/0049475520962742
131
Seung Joon Choi, Seong Min Kim, Yun Soo Kim, Oh Sang Kwon, Seung Kak Shin, Kyoung Kon Kim, Kiyoung Lee, Ie Byung Park, Cheol Soo Choi, Dong Hae Chung, Jaehun Jung, MunYoung Paek, Dae Ho Lee. Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver DiseaseDiabetes & Metabolism Journal 2021; 45(5): 739 doi: 10.4093/dmj.2020.0137
132
Samantha Maurotti, Roberta Pujia, Elisa Mazza, Maria Francesca Pileggi, Franco Arturi, Maria Grazia Tarsitano, Tiziana Montalcini, Arturo Pujia, Yvelise Ferro. Low Relative Handgrip Strength Is Associated with a High Risk of Non-Alcoholic Fatty Liver Disease in Italian Adults: A Retrospective Cohort StudyApplied Sciences 2023; 13(22): 12489 doi: 10.3390/app132212489
133
Paula Cenira Senger de CASTRO, Helen Caroline Perussolo ALBERTON, Maria Lucia Alves PEDROSO, Daphne Benatti Gonçalves MORSOLETTO, Alcindo PISSAIA JUNIOR, Cláudia Alexandra Pontes IVANTES. EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARSArquivos de Gastroenterologia 2019; 56(3): 256 doi: 10.1590/s0004-2803.201900000-48
134
Carlo Smirne, Violante Mulas, Matteo Nazzareno Barbaglia, Venkata Ramana Mallela, Rosalba Minisini, Nadia Barizzone, Michela Emma Burlone, Mario Pirisi, Elena Grossini. Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver DiseaseDiagnostics 2020; 10(12): 1003 doi: 10.3390/diagnostics10121003
135
Ji Yeon Seo, Eun Ju Cho, Min Joo Kim, Min‐Sun Kwak, Jong In Yang, Su Jin Chung, Jeong Yoon Yim, Ji Won Yoon, Goh Eun Chung. The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean populationJournal of Cachexia, Sarcopenia and Muscle 2022; 13(6): 2953 doi: 10.1002/jcsm.13099
136
Kyungsun Han, Ojin Kwon, Hyo-ju Park, So-Young Jung, Changsop Yang, Chang-Gue Son. Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trialTrials 2020; 21(1) doi: 10.1186/s13063-020-4068-y
137
Sanju Kumari, Mini George. Diagnostic Accuracy of a Nurse-Led Transient ElastographyGastroenterology Nursing 2023; 46(2): 118 doi: 10.1097/SGA.0000000000000707
138
Ying-ying Yu, Yu-ling Tong, Ling-yan Wu, Xin-yan Yu. Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trialScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23746-0
139
Luiz F. Viola, Cynthia M. Valerio, João M. Araujo-Neto, Fabio F. Santos, Felipe Matsuura, Rodrigo O. Moreira, Amélio F. Godoy-Matos. Waist circumference is independently associated with liver steatosis and fibrosis in LMNA-related and unrelated Familial Partial Lipodystrophy womenDiabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01156-0
140
Joana Rigor, Andreia Diegues, José Presa, Pedro Barata, Daniela Martins-Mendes. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese populationPostgraduate Medicine 2022; 134(4): 435 doi: 10.1080/00325481.2022.2058285
141
Frank Tacke, Paul Horn, Vincent Wai-Sun Wong, Vlad Ratziu, Elisabetta Bugianesi, Sven Francque, Shira Zelber-Sagi, Luca Valenti, Michael Roden, Fritz Schick, Hannele Yki-Järvinen, Amalia Gastaldelli, Roberto Vettor, Gema Frühbeck, Dror Dicker. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Journal of Hepatology 2024; 81(3): 492 doi: 10.1016/j.jhep.2024.04.031
142
FaisalA Alsaif, SaraH Alqahtani, AmaniM Alsadoon, KhalidA Alswat, AymanA Abdo, MazenM Hassanain, AbdulsalamB Alsharabi, GhadeerR Aljuhani, HishamM Alkhalidi, MohammadS Elsharkawy, MaramA Alotaibi, FaisalM Sanai, WaleedK Al-hamoudi. Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone diseaseSaudi Journal of Gastroenterology 2020; 26(4): 204 doi: 10.4103/sjg.SJG_29_20
143
Luis Chi-Cervera, Gordon Montalvo, María Icaza-Chávez, Julio Torres-Romero, Víctor Arana-Argáez, Mario Ramírez-Camacho, Julio Lara-Riegos. Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®)Journal of Medical Biochemistry 2021; 40(1): 60 doi: 10.5937/jomb0-24689
144
Leila Kamali, Atoosa Adibi, Shadi Ebrahimian, Fahime Jafari, Mohsen Sharifi. Diagnostic Performance of Ultrasonography in Detecting Fatty Liver Disease in Comparison with Fibroscan in People Suspected of Fatty LiverAdvanced Biomedical Research 2019; 8(1): 69 doi: 10.4103/abr.abr_114_19
145
Joshua Trowell, Joseph Alukal, Talan Zhang, Li Liu, Anurag Maheshwari, Hwan Y. Yoo, Paul J. Thuluvath. How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?Digestive Diseases and Sciences 2021; 66(4): 1297 doi: 10.1007/s10620-020-06269-4
146
Rohit Loomba, Anjali Jain, Anna Mae Diehl, Cynthia D. Guy, Dana Portenier, Ranjan Sudan, Seema Singh, Claire Faulkner, Lisa Richards, Kelly D. Hester, Lauren Okada, Xiao-jun Li, Larry Mimms, Manal F. Abdelmalek. Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology 2019; 17(9): 1867 doi: 10.1016/j.cgh.2018.11.004
147
Young-Kyu Kim, Oh-Sung Kwon, Kyu Hee Her. The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone diseaseMedicine 2019; 98(27): e16018 doi: 10.1097/MD.0000000000016018
148
Nicola Pugliese, Ludovico Alfarone, Ivan Arcari, Silvia Giugliano, Tommaso Lorenzo Parigi, Maria Rescigno, Ana Lleo, Alessio Aghemo. Clinical features and management issues of NAFLD-related HCC: what we know so farExpert Review of Gastroenterology & Hepatology 2023; 17(1): 31 doi: 10.1080/17474124.2023.2162503
149
Melissa Lopez-Pentecost, Martha Tamez, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or ObesityNutrients 2023; 15(23): 4997 doi: 10.3390/nu15234997
150
Anna E. Ferguson, Stavra A. Xanthakos, Robert M. Siegel. Challenges in Screening for Pediatric Nonalcoholic Fatty Liver DiseaseClinical Pediatrics 2018; 57(5): 558 doi: 10.1177/0009922817733300
151
Qun-Yan Yao, Ya-Dong Feng, Pei Han, Feng Yang, Guang-Qi Song. Hepatic microenvironment underlies fibrosis in chronic hepatitis B patientsWorld Journal of Gastroenterology 2020; 26(27): 3917-3928 doi: 10.3748/wjg.v26.i27.3917
152
Tanawat Jongraksak, Abhasnee Sobhonslidsuk, Janjira Jatchavala, Daruneewan Warodomwichit, Piyaporn Kaewduang, Somnuek Sungkanuparph. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive peopleInternational Journal of STD & AIDS 2021; 32(3): 266 doi: 10.1177/0956462420960997
153
Andrea de Diego-Sola, Agustín Castiella Eguzkiza, Luis María López Domínguez, Iratxe Urreta Barallobre, María José Sánchez Iturri, Joaquín María Belzunegui Otaño, Eva María Zapata Morcillo, Andrea de Diego-Sola, Agustin Castiella Eguzkiza, Luis María López Domínguez, Iratxe Urreta Barallobre, María José Sánchez Iturri, Cesar Antonio Egües Dubuc, Jorge Jesús Cancio Fanlo, Olga Maíz Alonso, Jesús Alejandro Valero Jaimes, María Vaamonde Lorenzo, Leire Samaniego Leoz, Joaquín Belzunegui Otaño, Eva María Zapata Morcillo. Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practiceReumatología Clínica 2023; 19(8): 412 doi: 10.1016/j.reuma.2022.12.003
154
Min‐Sun Kwak, Goh Eun Chung, Jong In Yang, Jeong Yoon Yim, Su Jin Chung, Se Young Jung, Joo Sung Kim. Clinical implications of controlled attenuation parameter in a health check‐up cohortLiver International 2018; 38(5): 915 doi: 10.1111/liv.13558
155
Paul Manka, Amos Zeller, Wing-Kin Syn. Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment ModalitiesDrugs 2019; 79(9): 903 doi: 10.1007/s40265-019-01126-9
156
Dorotea Bozic, Kristian Podrug, Ivana Mikolasevic, Ivica Grgurevic. Ultrasound Methods for the Assessment of Liver Steatosis: A Critical AppraisalDiagnostics 2022; 12(10): 2287 doi: 10.3390/diagnostics12102287
157
Matthias Buechter, Guido Gerken. Liver Function—How to Screen and to Diagnose: Insights from Personal Experiences, Controlled Clinical Studies and Future PerspectivesJournal of Personalized Medicine 2022; 12(10): 1657 doi: 10.3390/jpm12101657
158
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver diseaseThe Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
159
Marilena DURAZZO, Arianna FERRO. Novelties on non-invasive scores for the assessment of liver steatosisMinerva Gastroenterology 2023; 69(2) doi: 10.23736/S2724-5985.22.03210-7
160
Mohammadjavad Sotoudeheian. Agile 3+ and Metabolic Dysfunction-Associated Fatty Liver Disease: Detecting Advanced Fibrosis based on Reported Liver Stiffness Measurement in FibroScan and Laboratory FindingsThe International Journal of Gastroenterology and Hepatology Diseases 2024; 3 doi: 10.2174/0126662906302851240604042954
161
Gordon P. Watt, Isela De La Cerda, Jen‐Jung Pan, Michael B. Fallon, Laura Beretta, Rohit Loomba, Miryoung Lee, Joseph B. McCormick, Susan P. Fisher‐Hoch. Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population‐Based Study of Mexican AmericansHepatology Communications 2020; 4(12): 1793 doi: 10.1002/hep4.1603
162
Xiao Li, Ziwei Sun, Wei Liu, Lianjie Sun, Junyi Ren, Ying Xu, Haoyong Yu, Wenkun Bai. Methodology exploration and reproducibility evaluation of TAI and TSI for quantitative ultrasound assessment of hepatic steatosisHeliyon 2024; 10(11): e31904 doi: 10.1016/j.heliyon.2024.e31904
163
Antonella Mirizzi, Isabella Franco, Carla Maria Leone, Caterina Bonfiglio, Raffaele Cozzolongo, Maria Notarnicola, Vito Giannuzzi, Valeria Tutino, Valentina De Nunzio, Irene Bruno, Claudia Buongiorno, Angelo Campanella, Valentina Deflorio, Annamaria Pascale, Filippo Procino, Paolo Sorino, Alberto Rubén Osella. Effects of Some Food Components on Non-Alcoholic Fatty Liver Disease Severity: Results from a Cross-Sectional StudyNutrients 2019; 11(11): 2744 doi: 10.3390/nu11112744
164
Maneerat Chayanupatkul, Divya B. Dasani, Kristian Sogaard, Thomas D. Schiano. The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post–Liver Transplantation Using Transient Elastography With Controlled Attenuation ParameterTransplantation Proceedings 2021; 53(1): 159 doi: 10.1016/j.transproceed.2020.02.160
165
Willy Theel, Bianca M. Boxma‐de Klerk, Femme Dirksmeier‐Harinck, Elisabeth F. C. van Rossum, Danny A. Kanhai, Jan Apers, Bas M. van Dalen, Robert J. de Knegt, Adriaan G. Holleboom, Maarten E. Tushuizen, Diederick E. Grobbee, Janneke Wiebolt, Manuel Castro Cabezas. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniquesObesity Reviews 2022; 23(8) doi: 10.1111/obr.13481
166
Zahra Dehnavi, Farkhonde Razmpour, Mahmoud Belghaisi Naseri, Mohsen Nematy, Seyed Ali Alamdaran, Hassan Ali Vatanparast, Mohsen Azimi Nezhad, Bita Abbasi, Azita Ganji. Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63227
167
Audrey Kovatsch, Hanna Honcharova‐Biletska, Daniel Segna, Klaus Steigmiller, Sena Blümel, Rudolf A. Deibel, Tobias Kühlewindt, Georg Leinenkugel, Sandra Müller, Eva Furrer, Khoschy Schawkat, Cäcilia S. Reiner, Achim Weber, Beat Müllhaupt, Michael Scharl, Christoph Gubler, Christoph Jüngst. Performance of two‐dimensional shear wave elastography and transient elastography compared to liver biopsy for staging of liver fibrosisEuropean Journal of Clinical Investigation 2023; 53(7) doi: 10.1111/eci.13980
168
Isabella Angeli-Pahim, Anastasia Chambers, Sergio Duarte, Ali Zarrinpar. Current Trends in Surgical Management of Hepatocellular CarcinomaCancers 2023; 15(22): 5378 doi: 10.3390/cancers15225378
169
Duck Min Seo, Sang Min Lee, Ji Won Park, Min-Jeong Kim, Hong Il Ha, Sun-Young Park, Kwanseop Lee. How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?Ultrasonography 2023; 42(2): 227 doi: 10.14366/usg.22122
170
Paul R Armstrong, Éidín Ní Shé. Creating a framework for an integrated novel ultrasound clinic for metabolic dysfunction-associated steatotic liver diseaseBritish Journal of Healthcare Management 2024; 30(6): 1 doi: 10.12968/bjhc.2023.0037
171
Samira Saghafi, Elham Chamani, Fatemeh Salmani, Reza Fadaei, Efat Shafiei, Nariman Moradi, Tahmine Tavakoli. Genetic predisposition to nonalcoholic fatty liver disease: insights from ANGPTL8 gene variants in Iranian adultsLipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01905-0
172
Somaya Albhaisi, Abhijit Chowdhury, Arun J. Sanyal. Non-alcoholic fatty liver disease in lean individualsJHEP Reports 2019; 1(4): 329 doi: 10.1016/j.jhepr.2019.08.002
173
Yujuan Zhang, Liulan Xiang, Fang Qi, Yutian Cao, Wenhui Zhang, Tiansu Lv, Xiqiao Zhou. The metabolic profiles and body composition of non-obese metabolic associated fatty liver diseaseFrontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1322563
174
Thomas G. Cotter, Mary Rinella. Nonalcoholic Fatty Liver Disease 2020: The State of the DiseaseGastroenterology 2020; 158(7): 1851 doi: 10.1053/j.gastro.2020.01.052
175
Jonathan Mertens, Luc F. Van Gaal, Sven M. Francque, Christophe De Block. NAFLD in type 1 diabetes: overrated or underappreciated?Therapeutic Advances in Endocrinology and Metabolism 2021; 12 doi: 10.1177/20420188211055557
176
Ivana Mikolasevic, Sanja Stojsavljevic, Filip Blazic, Maja Mijic, Delfa Radic-Kristo, Toni Juric, Nadija Skenderevic, Mia Klapan, Andjela Lukic, Tajana Filipec Kanizaj. Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?World Journal of Transplantation 2021; 11(3): 37-53 doi: 10.5500/wjt.v11.i3.37
177
A. Mantovani, T. Turino, M.G. Lando, K. Gjini, C.D. Byrne, C. Zusi, F. Ravaioli, A. Colecchia, C. Maffeis, G. Salvagno, G. Lippi, E. Bonora, G. Targher. Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetesDiabetes & Metabolism 2020; 46(4): 296 doi: 10.1016/j.diabet.2019.11.004
178
Vítor Macedo Silva, Marta Freitas, Sofia Xavier, Pedro Boal Carvalho, Joana Magalhães, Carla Marinho, José Cotter. The New FibroScan-AST (FAST) Score: Enhancing Diabetes Mellitus Impact on Metabolic-Associated Fatty Liver DiseaseGE - Portuguese Journal of Gastroenterology 2023; 30(6): 422 doi: 10.1159/000527027
179
Mireen Friedrich-Rust, Fabian Schoelzel, Sebastian Maier, Florian Seeger, Julia Rey, Stephan Fichtlscherer, Eva Herrmann, Stefan Zeuzem, Joerg Bojunga, Pavel Strnad. Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center studyPLOS ONE 2017; 12(10): e0186720 doi: 10.1371/journal.pone.0186720
180
Tülay Çevik Saldiran, Fatma Karantay Mutluay, İlker Yağci, Yusuf Yilmaz. Impact of aerobic training with and without whole-body vibration training on metabolic features and quality of life in non-alcoholic fatty liver disease patientsAnnales d'Endocrinologie 2020; 81(5): 493 doi: 10.1016/j.ando.2020.05.003
181
S S Poul, K J Parker. Fat and fibrosis as confounding cofactors in viscoelastic measurements of the liverPhysics in Medicine & Biology 2021; 66(4): 045024 doi: 10.1088/1361-6560/abd593
182
Anirban Sinha, Biswabandhu Bankura. Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the Eastern region of IndiaDiabetes Epidemiology and Management 2023; 12: 100161 doi: 10.1016/j.deman.2023.100161
183
Mimi Zhou, Nan Yang, Xin Xing, Danyan Chang, Juan Li, Jiang Deng, Yi Chen, Chunhua Hu, Rou Zhang, Xiaolan Lu, Yingren Zhao, Yingli He. Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver diseaseBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01615-w
184
Yun Kyu Lee, Dong Hyeon Lee, Sae Kyung Joo, Heejoon Jang, Young Ho So, Siwon Jang, Dong Ho Lee, Jeong Hwan Park, Mee Soo Chang, Won Kim. Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver DiseaseGut and Liver 2024; 18(6): 1048 doi: 10.5009/gnl240198
185
Dae Ho Lee. Noninvasive Evaluation of Nonalcoholic Fatty Liver DiseaseEndocrinology and Metabolism 2020; 35(2): 243 doi: 10.3803/EnM.2020.35.2.243
186
PreyaJanubhai Patel, Fabrina Hossain, Leigh Ula Horsfall, Xuan Banh, Kelly Lee Hayward, Suzanne Williams, Tracey Johnson, Anne Bernard, Nigel Neil Brown, Guy Lampe, Lyndall Buck, Nivene Saad, Anthony William Russell, Patricia Casarolli Valery, Katharine Margaret Irvine, Andrew Donald Clouston, Katherine Anne Stuart, William Rosenberg, Elizabeth Ellen Powell. A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At‐Risk Populations in Primary CareHepatology Communications 2018; 2(8): 897 doi: 10.1002/hep4.1208
187
Alan A Parsa, Katie A Azama, May Vawer, Mel A Ona, Todd B Seto. Prevalence Study of MASLD in Adolescent and Young Adult Pacific Islanders and Asians Living in Hawai’iJournal of the Endocrine Society 2024; 8(3) doi: 10.1210/jendso/bvad165